MCAM and cerebral malaria: Recently, the interaction between CD146 and Gal-9 was reported to contribute to the aggregation of infected red blood cells and lymphocytes in a mouse experimental cerebral malaria system, indicating that the CD146–Gal-9 interaction could be a novel target for treating cerebral malaria [118].